Quick Answer
10x Genomics, Inc. reported Gross Profit of $443.88 million for fiscal year 2025.
10x Genomics, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $443.88M | +7.1% |
| 2024 | $414.48M | +1.3% |
| 2023 | $409.31M | +3.4% |
| 2022 | $396.02M | -4.9% |
| 2021 | $416.40M | +73.2% |
| 2020 | $240.38M | +30.0% |
| 2019 | $184.86M | +57.1% |
| 2018 | $117.65M | +94.4% |
| 2017 | $60.52M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $100.31M | -5.7% | -19.8% |
| June 30, 2025 | $125.08M | +20.0% | +18.6% |
| March 31, 2025 | $105.44M | +13.5% | -0.9% |
| September 30, 2024 | $106.39M | +11.4% | +2.1% |
| June 30, 2024 | $104.22M | +4.6% | +12.2% |
| March 31, 2024 | $92.91M | -5.6% | -2.7% |
| September 30, 2023 | $95.53M | -5.1% | -4.1% |
| June 30, 2023 | $99.61M | +14.6% | +1.2% |
- 10x Genomics, Inc. showed an increase of +7.1% in Gross Profit compared to the prior fiscal year.
- Over the 2017–2025 period, 10x Genomics, Inc.’s gross profit has grown by 633.4% (from $60.52 million to $443.88 million).
- The most recent figure is from 10x Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: